Combination pharmacotherapy with two or more drugs is required in order to reach the
currently recommended blood pressure goals in the majority of hypertensive patients …

Current blood pressure treatment guidelines call for a single drug to be tried first in people
with Stage 1 hypertension, ie those with a systolic reading over 140 mmHg and a diastolic …

Both in clinical practice and in drug trials, combination treatment of hypertension plays a
fundamental role. This article reviews the features that make combined therapy with two …

Introduction: Hypertension is one of the primary modifiable risk factor for cardiac and renal
diseases with the prevalence around 30–45% of the general population, with a steep …

Thoughtful use of drug combinations is critical for achieving therapeutic objectives in
hypertensive individuals and populations–more rapid BP control and more effective …

Editor's Note: The American Society of Hypertension is publishing a series of Position
Papers in their official journals throughout the 2008–2011 years. The following Position …

The majority of patients with hypertension need at least two antihypertensive agents to
achieve blood pressure (BP) objectives. As current European guidelines for the treatment of …

The rationale behind employing combination antihypertensive therapy stems from growing
evidence that there is a greater need for more aggressive control of systemic arterial …

Myocardial infarction, stroke, and congestive heart failure are the leading causes of death
and disability in developed countries. Hypertension is one of the most important risk factors …

Aim: To review the various pharmacological approaches currently proposed for the
treatment of hypertension. Results: With the evolution of pharmacological treatment of …